Search results
Results from the WOW.Com Content Network
Donepezil (brand name Aricept) may be used to treat dementia caused by Alzheimer's disease. Donepezil can help improve attention, memory, behavior, and ability to do daily activities in dementia patients.
Donepezil is commonly used to treat mild, moderate, and severe dementia related to Alzheimer’s disease. Donepezil may also be used for other conditions as determined by your healthcare provider.
Donepezil is used to treat dementia (memory loss and mental changes) associated with mild, moderate, or severe Alzheimer's disease. Donepezil will not cure Alzheimer's disease, and it will not stop the disease from getting worse. However, it can improve thinking ability in some patients.
Donepezil helps control the symptoms of Alzheimer's disease but does not cure it. Continue to take donepezil even if you feel well. Do not stop taking donepezil without talking to your doctor. Your doctor may start you on a low dose of donepezil and increase your dose after 4 to 6 weeks.
The risk or severity of adverse effects can be increased when Donepezil is combined with Varenicline. The therapeutic efficacy of Vecuronium can be decreased when used in combination with Donepezil. Velpatasvir may decrease the excretion rate of Donepezil which could result in a higher serum level.
Donepezil is a medication that treats symptoms of Alzheimer’s disease like memory loss and confusion. This medication works by improving your attention, memory and ability to engage in your daily activities.
Aricept generic name is donepezil. Aricept improves the function of nerve cells in the brain. Aricept works by preventing the breakdown of a chemical called acetylcholine (ah SEET il KOE leen).
23mg. tablet, oral disintegrating. 5mg. 10mg. Alzheimer Disease. Indicated for dementia of the Alzheimer type. Mild to moderate. 5 mg PO qHS initially, may increase to 10 mg/day after 4-6 weeks if...
Cholinesterase inhibitors (e.g., donepezil, galantamine, rivastigmine) are used for symptomatic management of dementia associated with Alzheimer's disease; however, these drugs have been shown to provide only modest benefits and do not alter the underlying dementing process.
Last updated January 15, 2020. Includes Donepezil indications, dosage/administration, pharmacology, mechanism/onset/duration of action, half-life, dosage forms, interactions, warnings, adverse reactions, off-label uses and more.